Proactive Investors - Run By Investors For Investors

Braingrid unit teams up with Scanit Technologies to support cannabis growers

The subsidiary will integrate its technology and cloud platform with Scanit's on-premises systems to provide metrics for airborne disease detection
A marijuana plant
Disease is a key concern for cannabis growers, according to Braingrid

Braingrid Ltd (CSE:BGRD) (OTCMKTS:BGRDF) announced Tuesday that its subsidiary has entered into an integration agreement with Scanit Technologies Inc to support cannabis growers.

Under their three-year agreement, Braingrid Corp will integrate its Sentroller technology and cloud platform with Scanit's on-premises systems to provide metrics for airborne disease detection, along with Braingrid's wireless, environmental, monitoring technology.

The agreement allows Braingrid and Scanit to each provide their analytics on one screen to make a grower's job easier and take swift action to avoid disease outbreaks.

READ: Braingrid unveils strategic tie-up with A&L Canada Laboratories

Toronto-based Braingrid added that the companies will explore different business combinations, including a role for Braingrid as a value-added reseller. No terms have yet been determined, according to Braingrid.

Scanit, located in Fremont, California, has developed equipment and software to provide in near real-time, early airborne disease detection for outdoor and indoor growers. This solution detects, measures and identifies airborne diseases that are causing yield losses and crop failures before they are visible.

Disease, especially powdery mildew and botrytis, is a key concern for most cannabis growers and cost the industry millions of dollars in lost product, according to Braingrid.

"Growers who use Scanit and Braingrid solutions will be at the leading edge of early disease detection,” Braingrid CEO Michael Kadonoff said in a statement.

‘Meaningful insights’

Scanit CEO Pete Manautou added that “the critical data from both our systems will produce meaningful insights to our grower customers, enabling them to optimize yields and operational costs.”

Shares of Braingrid traded at C$0.18 in Monday’s Canadian trading. They fetched US$0.14 on the OTC Markets.

Last month, the company announced that it had struck up a partnership with A&L Canada Laboratories.

Under the terms of their three-year deal, Braingrid will serve as the mobile field lab supplier of real-time data to clients of A&L, an agricultural testing lab with a focus on cannabis.

Contact Dennis Fitzgerald at [email protected]

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full BGRD profile View Profile

Braingrid Ltd. Timeline

March 05 2019

Related Articles

Video conference call
June 14 2019
The company’s core software-as-a-service product aims to make audio conferencing simpler, and more productive
G Medical's Prizma device
January 21 2019
The mobile and e-health company is set for first production from its facility in Guangzhou, China.
Artist Michael Foran photographs the burning US Twin Towers after the 9/11 attacks
April 09 2019
The information sharing platform archTIS commercially launched this week was inspired by the threat of the 9/11 attacks in the US and is continually relevant amid global tensions.
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use